Ayrton Capital LLC 13D and 13G filings for Lucid Diagnostics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 1:38 pm Sale |
2024-12-31 | 13G | Lucid Diagnostics Inc. LUCD |
Ayrton Capital LLC | 1,200,485 2.000% |
-3,755,213 (-75.78%) |
Filing |
| 2024-07-08 3:49 pm Purchase |
2023-12-31 | 13G | Lucid Diagnostics Inc. LUCD |
Ayrton Capital LLC | 4,955,698 9.900% |
3,792,069 (+325.88%) |
Filing |
| 2024-02-14 3:38 pm Sale |
2023-12-31 | 13G | Lucid Diagnostics Inc. LUCD |
Ayrton Capital LLC | 1,163,629 9.900% |
-1,058,593 (-47.64%) |
Filing |
| 2023-03-24 2:09 pm Sale |
2023-03-13 | 13G | Lucid Diagnostics Inc. LUCD |
Ayrton Capital LLC | 2,222,222 4.870% |
-2,593,945 (-53.86%) |
Filing |
| 2023-03-23 2:25 pm Purchase |
2023-03-13 | 13G | Lucid Diagnostics Inc. LUCD |
Ayrton Capital LLC | 4,816,167 9.990% |
4,816,167 (New Position) |
Filing |